A detailed history of Granite Harbor Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Granite Harbor Advisors, Inc. holds 1,800 shares of ABBV stock, worth $309,114. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,800
Previous 1,377 30.72%
Holding current value
$309,114
Previous $236 Million 50.5%
% of portfolio
0.21%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $69,304 - $84,316
423 Added 30.72%
1,800 $355 Million
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $1,547 - $1,807
10 Added 0.73%
1,377 $236 Million
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $218,473 - $248,930
1,367 New
1,367 $249 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Granite Harbor Advisors, Inc. Portfolio

Follow Granite Harbor Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Harbor Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Granite Harbor Advisors, Inc. with notifications on news.